Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from patients with severe acute respiratory syndrome - PubMed (original) (raw)

Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from patients with severe acute respiratory syndrome

Xiao-Yan Che et al. J Clin Microbiol. 2004 Jun.

Abstract

A rapid antigen test for the diagnosis of severe acute respiratory syndrome (SARS) is essential for control of this disease at the point of management. The nucleocapsid (N) protein of SARS-associated coronavirus (SARS-CoV) is abundantly expressed in infected-cell culture filtrate as demonstrable by Western blotting using convalescent-phase sera from patients with SARS. We used monoclonal antibodies specifically directed against N protein to establish a sensitive antigen capture sandwich enzyme-linked immunosorbent assay (ELISA) for the detection of SARS-CoV. The assay employed a mixture of three monoclonal antibodies for capture and rabbit polyclonal antibodies for detection of serum antigen in 32 cases of clinically probable SARS as defined by the World Health Organization during the epidemic in Guangzhou, China. Recombinant N protein was used as a standard to establish a detection sensitivity of approximated 50 pg/ml. The linear range of detection in clinical specimens was from 100 pg/ml to 3.2 ng/ml. Using a panel of sera collected at different points in time, the amount of circulating N antigen was found to peak 6 to 10 days after the onset of symptoms. The sensitivity of the assay was 84.6% in 13 serologically confirmed SARS patients with blood taken during the first 10 days after the onset of symptoms (11 of 13). The specificity of the assay was 98.5% in 1,272 healthy individuals (1,253 of 1,272). There was no cross-reaction with other human and animal coronaviruses in this assay. In conclusion, a sensitive and quantitative antigen capture ELISA was established for the early diagnosis and disease monitoring of SARS-CoV infection.

PubMed Disclaimer

Figures

FIG. 1.

FIG. 1.

(A) Western blot analysis of monoclonal antibodies to recombinant N protein. Purified GST-N fusion protein was separated on the sodium dodecyl sulfate-10% polyacrylamide gel and transferred onto a nitrocellulose membrane. The strips were reacted with different anti-N protein monoclonal antibodies. Lanes 1 to 4: different monoclonal antibody clones (N1E8, N8E1, N10E4, and N10A4, respectively). (B and C) Western blot analysis of N protein in the culture filtrate of SARS-CoV. Culture filtrate from the Vero cells infected with SARS-CoV was concentrated and separated on the sodium dodecyl sulfate-10% polyacrylamide gel and transferred onto a nitrocellulose membrane. The strips were reacted with different anti-N protein monoclonal antibodies, control monoclonal antibodies and convalescent SARS patient sera, respectively. (B) Lanes 1 to 11, different monoclonal antibody clones (N1E8, N8E1, N10E4, N10A4, N14A3, N14E19, N14E7, N14E1, N14B6, N10E2, and N1A7, respectively); lanes 12 to 14, control monoclonal antibodies. (C) Lanes 1 to 12: 12 cases' sera; lane 13, normal serum control.

FIG. 2.

FIG. 2.

Reproducibility of standard curve of N protein determine with a purified recombinant N protein. Various concentrations of N protein dilution were measured in duplicate by antigen capture ELISA. Results were mean values from three separate plates run under same conditions. Data points represent the means (error bars, standard deviations).

FIG. 3.

FIG. 3.

Capture ELISA detection of N protein from Vero cells infected with SARS-CoV. Virus culture filtrate was isolated from Beijing (BJ01) (□), from HK (HKU-39849) (▪), from Guangdong (GZ01) (▴) (Vero cells culture filtrate, ♦).

FIG. 4.

FIG. 4.

N antigen detection in 57 serum specimens from 32 patients with SARS. Data represent the OD450 of sera tested at a dilution of 1/2. (dotted line) cutoff values.

References

    1. Cano, H., M. J. Candela, M. L. Lozano, and V. Vicente. 2003. Application of a new enzyme-linked immunosorbent assay for detection of total hepatitis C virus core antigen in blood donors. Transfus. Med. 13:259-266. - PubMed
    1. Chan, K. H., L. L. Poon, V. C. Cheng, Y. Guan, I. F. Hung, J. Kong, L. Y. Yam, W. H. Seto, K. Y. Yuen, and J. S. Peiris. 2004. Detection of SARS coronavirus in patients with suspected SARS. Emerg. Infect. Dis. 10:294-299. - PMC - PubMed
    1. Clement, F., P. Dewint, and G. Leroux-Roels. 2002. Evaluation of a new rapid test for the combined detection of hepatitis B virus surface antigen and hepatitis B virus e antigen. J. Clin. Microbiol. 40:4603-4606. - PMC - PubMed
    1. Crouch, C. F., T. J. G. Raybould, and S. D. Acres. 1984. Monoclonal antibody capture enzyme-linked immunosorbent assay for detection of bovine enteric coronavirus. J. Clin. Microbiol. 19:388-393. - PMC - PubMed
    1. Deshpande, S. S. 1996. Enzyme immunoassay from concept to product development, 1st ed., p. 401-423. Kluwer Academic Publishers, New York, N.Y.

Publication types

MeSH terms

Substances

LinkOut - more resources